Twist Bioscience (TWST) Stock Forecast & Price Target

Compare

1,204 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TWST Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Twist

Bioscience

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TWST Stock 12 Month Forecast

Average Price Target

$52.00

▼(-1.66% Downside)

Based on 6 Wall Street analysts offering 12 month price targets for Twist Bioscience in the last 3 months. The average price target is $52.00 with a high forecast of $58.00 and a low forecast of $50.00. The average price target represents a -1.66% change from the last price of $52.88.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"25":"$25","42":"$42","59":"$59","33.5":"$33.5","50.5":"$50.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":58,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$58.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":52,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$52.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":50,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$50.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[25,33.5,42,50.5,59],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,46.81,47.67076923076923,48.53153846153846,49.392307692307696,50.253076923076925,51.113846153846154,51.97461538461538,52.83538461538462,53.69615384615385,54.55692307692308,55.417692307692306,56.27846153846154,57.13923076923077,{"y":58,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,46.81,47.20923076923077,47.60846153846154,48.00769230769231,48.40692307692308,48.80615384615385,49.20538461538462,49.604615384615386,50.003846153846155,50.403076923076924,50.80230769230769,51.20153846153846,51.60076923076923,{"y":52,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,46.81,47.05538461538462,47.300769230769234,47.54615384615385,47.791538461538465,48.03692307692308,48.2823076923077,48.527692307692305,48.77307692307692,49.01846153846154,49.26384615384615,49.50923076923077,49.754615384615384,{"y":50,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":52.37,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.82,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.94,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.71,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.065,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.75,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.68,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.24,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.26,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.89,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.86,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.72,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.81,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$58.00

Average Price Target$52.00

Lowest Price Target$50.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matt Larew

William Blair

Buy

―

Reiterated

02/17/26

Twist Bioscience: Invenra Licensing Deal Strengthens AI-Driven Bispecific Antibody Platform and Supports Outperform Rating

Catherine Ramsey Schulte

Robert W. Baird

$33→$50

Buy

-5.45%

Downside

Reiterated

02/03/26

Twist Bioscience price target raised to $50 from $33 at BairdTwist Bioscience price target raised to $50 from $33 at Baird

Vijay Kumar

Evercore ISI

$42→$52

Buy

-1.66%

Downside

Reiterated

02/03/26

Twist Bioscience price target raised to $52 from $42 at Evercore ISITwist Bioscience price target raised to $52 from $42 at Evercore ISI

Luke Sergott

Barclays

$39→$50

Buy

-5.45%

Downside

Reiterated

02/03/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Subbu Nambi

Guggenheim

$50

Buy

-5.45%

Downside

Reiterated

02/02/26

Analysts Offer Insights on Healthcare Companies: Cytokinetics (NASDAQ: CYTK), Twist Bioscience (NASDAQ: TWST) and Centene (NYSE: CNC)

Brendan Smith

TD Cowen

$43→$58

Buy

9.68%

Upside

Reiterated

02/02/26

Analysts Are Bullish on Top Healthcare Stocks: Pelthos Therapeutics (PTHS), Twist Bioscience (TWST)

Steven Etoch

Stephens

$41

Buy

-22.47%

Downside

Initiated

11/03/25

Twist Bioscience initiated with an Overweight at StephensTwist Bioscience initiated with an Overweight at Stephens

Rachel Vatnsdal

J.P. Morgan

$33→$25

Sell

-52.72%

Downside

Reiterated

08/05/25

J.P. Morgan Keeps Their Sell Rating on Twist Bioscience (TWST)

Puneet Souda

Leerink Partners

$35

Hold

-33.81%

Downside

Reiterated

08/04/25

Analysts Are Neutral on These Healthcare Stocks: Moderna (MRNA), Twist Bioscience (TWST)

Sung Ji Nam

Scotiabank

$62

Buy

17.25%

Upside

Reiterated

05/06/25

Scotiabank Remains a Buy on Twist Bioscience (TWST)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matt Larew

William Blair

Buy

―

Reiterated

02/17/26

Twist Bioscience: Invenra Licensing Deal Strengthens AI-Driven Bispecific Antibody Platform and Supports Outperform Rating

Catherine Ramsey Schulte

Robert W. Baird

$33→$50

Buy

-5.45%

Downside

Reiterated

02/03/26

Twist Bioscience price target raised to $50 from $33 at BairdTwist Bioscience price target raised to $50 from $33 at Baird

Vijay Kumar

Evercore ISI

$42→$52

Buy

-1.66%

Downside

Reiterated

02/03/26

Twist Bioscience price target raised to $52 from $42 at Evercore ISITwist Bioscience price target raised to $52 from $42 at Evercore ISI

Luke Sergott

Barclays

$39→$50

Buy

-5.45%

Downside

Reiterated

02/03/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Subbu Nambi

Guggenheim

$50

Buy

-5.45%

Downside

Reiterated

02/02/26

Analysts Offer Insights on Healthcare Companies: Cytokinetics (NASDAQ: CYTK), Twist Bioscience (NASDAQ: TWST) and Centene (NYSE: CNC)

Brendan Smith

TD Cowen

$43→$58

Buy

9.68%

Upside

Reiterated

02/02/26

Analysts Are Bullish on Top Healthcare Stocks: Pelthos Therapeutics (PTHS), Twist Bioscience (TWST)

Steven Etoch

Stephens

$41

Buy

-22.47%

Downside

Initiated

11/03/25

Twist Bioscience initiated with an Overweight at StephensTwist Bioscience initiated with an Overweight at Stephens

Rachel Vatnsdal

J.P. Morgan

$33→$25

Sell

-52.72%

Downside

Reiterated

08/05/25

J.P. Morgan Keeps Their Sell Rating on Twist Bioscience (TWST)

Puneet Souda

Leerink Partners

$35

Hold

-33.81%

Downside

Reiterated

08/04/25

Analysts Are Neutral on These Healthcare Stocks: Moderna (MRNA), Twist Bioscience (TWST)

Sung Ji Nam

Scotiabank

$62

Buy

17.25%

Upside

Reiterated

05/06/25

Scotiabank Remains a Buy on Twist Bioscience (TWST)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Twist Bioscience

3 Months

xxx

Success Rate

8/13 ratings generated profit

Average Return

+0.44%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +0.44% per trade.

1 Year

Brendan SmithTD Cowen

Success Rate

8/12 ratings generated profit

Average Return

+21.38%

a rating ―

Copying Brendan Smith's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +21.38% per trade.

2 Years

xxx

Success Rate

10/12 ratings generated profit

Average Return

+31.44%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +31.44% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TWST Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TWST has received 13 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TWST average Analyst price target in the past 3 months is 52.00.

Each month's total comprises the sum of three months' worth of ratings.

TWST Financial Forecast

TWST Earnings Forecast

Next quarter’s earnings estimate for TWST is -$0.48 with a range of -$0.61 to -$0.21. The previous quarter’s EPS was -$0.50. TWST beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year TWST has Performed in-line its overall industry.

TWST Sales Forecast

Next quarter’s sales forecast for TWST is $107.68M with a range of $107.24M to $108.00M. The previous quarter’s sales results were $103.70M. TWST beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year TWST has Performed in-line its overall industry.

TWST Stock Forecast FAQ

What is TWST’s average 12-month price target, according to analysts?

Based on analyst ratings, Twist Bioscience Corp’s 12-month average price target is 52.00.

What is TWST’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for TWST, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TWST a Buy, Sell or Hold?

Twist Bioscience Corp has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is Twist Bioscience Corp’s price target?

The average price target for Twist Bioscience Corp is 52.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $58.00 ,the lowest forecast is $50.00. The average price target represents -1.66% Decrease from the current price of $52.88.

What do analysts say about Twist Bioscience Corp?

Twist Bioscience Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of TWST?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Twist Bioscience (TWST) Stock Forecast & Price Target

TWST Analyst Ratings

TWST Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Twist Bioscience

TWST Analyst Recommendation Trends

TWST Financial Forecast

TWST Earnings Forecast

TWST Sales Forecast

TWST Stock Forecast FAQ

Detailed List of Analyst Forecasts